SCHEMBL761402

SCHEMBL761402

C[Si](C)(C)c1ccc(N(c2ccccc2)c2ccc3c(-c4ccccc4-c4ccccc4)c4cc(N(c5ccccc5)c5ccc([Si](C)(C)C)cc5)ccc4c(-c4ccccc4-c4ccccc4)c3c2)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTAFR P25105 1/20 0.32
ALDH1A1 P00352 3/20 0.31
TDP1 Q9NUW8 3/20 0.31
MAPT P10636 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
KDM4E B2RXH2 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
MEN1 O00255 3/20 0.30
KMT2A Q03164 3/20 0.30
USP2 O75604 1/20 0.30
MAPK1 P28482 1/20 0.30
CTNNB1 P35222 1/20 0.30
ATM Q13315 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
HSD17B10 Q99714 1/20 0.30
ADRA2A P08913 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL761434 0.96 PTAFR (0.33) PTAFRALDH1A1TDP1MAPTL3MBTL1
SCHEMBL762127 0.93 PTAFR (0.33) PTAFRALDH1A1TDP1MAPTL3MBTL1
SCHEMBL14515982 0.87 TDP1 (0.33) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL37086 0.87 ALDH1A1 (0.37) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL18561896 0.87 ALDH1A1 (0.37) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL760840 0.86 TDP1 (0.33) PTAFRALDH1A1TDP1MAPTL3MBTL1
SCHEMBL762122 0.86 CRHR1 (0.34) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL1103705 0.86 L3MBTL1 (0.36) ALDH1A1TDP1MAPTL3MBTL1KDM4E
SCHEMBL760861 0.85 ACHE (0.33) PTAFRALDH1A1TDP1MAPTL3MBTL1
SCHEMBL14516043 0.85 ACHE (0.33) PTAFRALDH1A1TDP1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8137823-B2 Anthracene derivatives, process for preparation thereof, and organic electronic light emitting device using the same LG CHEM, LTD. (KR) 2012-03-20 US disclosed
US-20090079334-A1 Novel Anthracene Derivatives, Process for Preparation Thereof, and Organic Electronic Light Emitting Device Using the Same LG CHEM, LTD. (KR) 2009-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090079334-A1 Novel Anthracene Derivatives, Process for Preparation Thereof, and Organic Electronic Light Emitting Device Using the Same XPOT, ALAD, APRT PTAFR 4759/4885ALDH1A1 434/4885TDP1 2558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.